financetom
Business
financetom
/
Business
/
Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says
Apr 3, 2025 1:59 AM

04:35 AM EDT, 04/03/2025 (MT Newswires) -- The slate of tariffs from the Trump administration is "worse than the worst case scenario" feared by analysts, according to Wedbush Securities.

In a note emailed to clients on Wednesday, Wedbush analysts, led by Daniel Ives, said tech stocks will be under "major pressure" following the announcement.

On Wednesday, the Trump administration unveiled another wave of tariffs to be imposed on many countries, including China and Taiwan, as well as the European Union.

The analysts said investors will focus on the details of the tariffs over the next 24 hours but for Apple ( AAPL ) , which produces iPhones in China, the focus will be on possible exemptions from the tariff policy if it builds more factories in the US. For Nvidia ( NVDA ) and other chipmakers, the focus will be on pricing and margin impacts, the analysts said.

"[W]e continue to believe there are off ramps and major negotiations that will happen over the coming months with various countries and companies to navigate this new world of tariffs," the analysts said.

Wedbush analysts described the 34% reciprocal tariff levied on China as "the jaw dropper," followed by Taiwan's tariff rate at 32% and the EU at 20%.

China said it opposes the tariffs, calling them a "typical unilateral bullying practice," and vowed to take countermeasures to protect its rights and interests, media outlets reported, citing a statement from the country's Ministry of Commerce.

The latest 34% reciprocal tariff levied on China is in addition to the existing 20% tariff imposed on all Chinese products imported to the US.

Taiwan and the EU also said they would take countermeasures to the tariffs if negotiations with the Trump administration fail.

In a live-streamed broadcast, European Commission President Ursula von der Leyen said the EU is ready to respond and is preparing countermeasures against the US tariffs, according to reports.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved